- Filed
- Mar 2, 2015 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2014 · Nov 5, 2014 | 63.72M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2014 | 63.69M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2014 | 63.48M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2013 | 66.83M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2013 | 65.03M sh |
| Capex | Q3 2014 · Sep 30, 2014 | $13.38M |
| Capex | Q3 2014 · Sep 30, 2013 | $4.11M |
| Cash And Equivalents | Q3 2014 · Sep 30, 2014 | $422.58M |
| Cash And Equivalents | Q3 2014 · Dec 31, 2013 | $1.16B |
| Cash And Equivalents | Q3 2014 · Sep 30, 2013 | $817.73M |
| Cash And Equivalents | Q3 2014 · Dec 31, 2012 | $751.01M |
| Stockholders Equity restated | Q3 2014 · Sep 30, 2014 | $517.71M |
| Stockholders Equity restated | Q3 2014 · Dec 31, 2013 | $728.64M |
| Current Liabilities restated | Q3 2014 · Sep 30, 2014 | $1.6B |
| Current Liabilities restated | Q3 2014 · Dec 31, 2013 | $417.24M |
| Current Assets restated | Q3 2014 · Sep 30, 2014 | $1.49B |
| Current Assets restated | Q3 2014 · Dec 31, 2013 | $2.28B |
| Total Assets restated | Q3 2014 · Sep 30, 2014 | $4.82B |
| Total Assets restated | Q3 2014 · Dec 31, 2013 | $2.93B |
| Eps Diluted | Q3 2014 · Sep 30, 2014 | −$1.46 |
| Eps Diluted restated | Q3 2014 · Sep 30, 2014 | −$2.00 |
| Eps Diluted | Q3 2014 · Sep 30, 2013 | $0.71 |
| Eps Diluted | Q3 2014 · Sep 30, 2013 | $1.40 |
| Eps Basic | Q3 2014 · Sep 30, 2014 | −$1.46 |
| Eps Basic restated | Q3 2014 · Sep 30, 2014 | −$2.00 |
| Eps Basic | Q3 2014 · Sep 30, 2013 | $0.77 |
| Eps Basic | Q3 2014 · Sep 30, 2013 | $1.48 |
| Sga Expense | Q3 2014 · Sep 30, 2014 | $177.58M |
| Sga Expense restated | Q3 2014 · Sep 30, 2014 | $523.04M |
| Sga Expense restated | Q3 2014 · Sep 30, 2013 | $76.2M |
| Sga Expense restated | Q3 2014 · Sep 30, 2013 | $251.63M |
| Rd Expense | Q3 2014 · Sep 30, 2014 | $36.68M |
| Rd Expense restated | Q3 2014 · Sep 30, 2014 | $103.48M |
| Rd Expense restated | Q3 2014 · Sep 30, 2013 | $29.18M |
| Rd Expense restated | Q3 2014 · Sep 30, 2013 | $85.89M |
| Net Income | Q3 2014 · Sep 30, 2014 | −$93.11M |
| Net Income restated | Q3 2014 · Sep 30, 2014 | −$127.27M |
| Net Income | Q3 2014 · Sep 30, 2013 | $47.33M |
| Net Income | Q3 2014 · Sep 30, 2013 | $90.77M |
| Operating Income | Q3 2014 · Sep 30, 2014 | −$89.42M |
| Operating Income restated | Q3 2014 · Sep 30, 2014 | −$66.66M |
| Operating Income | Q3 2014 · Sep 30, 2013 | $76.31M |
| Operating Income | Q3 2014 · Sep 30, 2013 | $175.73M |
| Cost Of Revenue | Q3 2014 · Sep 30, 2014 | $86.11M |
| Cost Of Revenue restated | Q3 2014 · Sep 30, 2014 | $307.62M |
| Cost Of Revenue | Q3 2014 · Sep 30, 2013 | $42.9M |
| Cost Of Revenue | Q3 2014 · Sep 30, 2013 | $122.46M |
| Revenue | Q3 2014 · Sep 30, 2014 | $341.55M |
| Revenue restated | Q3 2014 · Sep 30, 2014 | $1.12B |
| Revenue | Q3 2014 · Sep 30, 2013 | $238.18M |
| Revenue | Q3 2014 · Sep 30, 2013 | $676.23M |